91黑料 experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
on the role of Chief Medical Officers.
-
This explores the increase in antimicrobial-resistant infections such as C diff due to the high volume of patients being treated in hosipitals for COVID-19.
This article is taken from European Biopharmaceutical Review October 2020, pages 12-14. Samedan Ltd.
-
A Pharmaphorum article which considers how bringing clinical trials to patients – rather than the reverse – could be the key to improving recruitment into studies and making them faster, cheaper and more likely to succeed.
-
91黑料 experts Andreas Dreps and Martin Lachs share their thoughts on the future of cancer research and the importance of staying adaptive in PharmaPhorum's '' magazine.
-
This article featured in ClinicalOmics '' (pages 48 & 49) considers how cell and gene therapies are playing an increasingly important role in treating oncology patients.
-
A panel discussion providing .
-
91黑料's Tim Clark and Will Maier examine the key clinical, regulatory, and commercial challenges associated with the development of therapies for the treatment of rare diseases.
-
A thought leadership article authored by Marie McCarthy, Tim Clark and Peter Schueler on .
-
A conversation with an expert in drug development
Colin Orford, Senior Vice President of Drug Development services at 91黑料, about finding an effective treatment for COVID-19.
-
Real world data is rapidly becoming the latest frontier for life sciences companies for supporting regulatory filings and conducting drug safety surveillance.
